Faslodex Dosage Information: Details on Strength, Form, Administration, and Additional Facts
Faslodex, a brand-name drug approved by the FDA, is often prescribed for postmenopausal women with hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. This drug, known as fulvestrant, belongs to a class of drugs called estrogen receptor antagonists and acts as a selective estrogen receptor degrader (SERD).
If you are a postmenopausal woman with this type of breast cancer and have not received hormone therapy before, or if your cancer has worsened after receiving a different hormone therapy in the past, your doctor may consider Faslodex as a treatment option.
Faslodex is typically prescribed at a dose of 500 mg given by intramuscular injection on day 1, day 15, day 29, and then once monthly thereafter. This regimen is designed to ensure adequate receptor saturation and degradation.
The usual administration schedule for Faslodex is as follows:
- 500 mg intramuscular injection on day 1 (first dose)
- A second 500 mg dose on day 15
- A third 500 mg dose on day 29
- Maintenance doses of 500 mg every 28 days (monthly) thereafter
It is essential to note that the dosage your doctor prescribes may depend on certain factors, including your age and liver function. If you have liver damage, your doctor may lower your Faslodex dosage.
Faslodex is available in a generic version and may be combined with other agents like CDK4/6 inhibitors (e.g., ribociclib) for enhanced efficacy, especially after progression on prior endocrine therapy.
If you miss a scheduled appointment for your Faslodex dose, contact your doctor's office right away to reschedule. Using a reminder system, such as setting an alarm or using a calendar app, can help ensure you don't miss an appointment.
For more information about Faslodex, additional articles about the drug, its side effects, and details about your condition may be helpful. It is always a good idea to discuss any questions or concerns you have with your healthcare provider.
- Faslodex, a drug used for treating hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, is a selective estrogen receptor degrader (SERD) known as fulvestrant.
- If you are a postmenopausal woman with breast cancer and your condition has worsened after receiving a different hormone therapy in the past, your doctor may consider Faslodex as a treatment option.
- The usual Faslodex administration schedule includes a first dose of 500 mg intramuscular injection, followed by subsequent doses on days 15 and 29, and maintenance doses of 500 mg every 28 days (monthly) thereafter.
- The dosage of Faslodex you'll receive may depend on factors like your age and liver function, and if you have liver damage, your doctor may lower your dosage.
